AGEWISE: Exploring how the gut microbiome and hormones change as women age
Official title: AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing
Run by Gulbenkian Institute for Molecular Medicine · NCT07614542 · Data updated 2026-11-12
This study will look at how the gut microbiome relates to hormonal changes during menopause in healthy women aged 40–64 in Portugal to see if biomarkers can help predict health risks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 64 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Gulbenkian Institute for Molecular Medicine Academic / other |
| Locations | 1 site (Lisbon) |
| Status | Recruiting |
| Started | June 2, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2036 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT07614542 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy women aged 40–64 who reside in mainland Portugal or the islands and are willing to provide stool and blood samples and complete three questionnaires.
✕Probably not a fit
Participants without menopause-related changes or lacking identifiable biomarkers may not receive direct benefits beyond contributing to research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
AGEWISE is an observational study in healthy women aged 40–64 living in Portugal. Researchers will collect stool and blood samples and have participants complete questionnaires about health, lifestyle, diet, and menopausal symptoms. The goal is to link gut microbiome data with hormone levels and inflammation markers to understand menopause-related ageing and identify potential biomarkers for personalized risk assessment. Findings may inform prevention strategies for age-related health issues in women. No intervention is involved; the study observes natural changes across the menopausal transition.
Why it matters
Potential benefit: If successful, the study could identify microbiome and blood biomarkers that help tailor prevention strategies for menopause-related health risks.
How similar studies have gone: Prior studies have shown relationships between the gut microbiome, hormones, and inflammation in ageing, supporting the plausibility of this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex * Aged 40 to 64 years * Resident in mainland Portugal or the islands * Able and willing to provide written informed consent * Willing to provide stool and blood samples and complete three questionnaires Exclusion Criteria: * Age below 40 years or 65 years and older * Inability to give informed consent * Refusal to provide stool or blood samples or complete questionnaires * Pregnancy * Diagnosed gastrointestinal disorders (including inflammatory bowel disease, Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic diarrhoea of unknown cause, or recurrent Clostridioides difficile infection) * Active oncological disease
Where it's running
-
Gulbenkian Institute for Molecular Medicine, Lisbon
Lisbon, Portugal Recruiting
Study contacts
- Study coordinator: Ana S Almeida, PhD
- Email: ana.almeida@gimm.pt
- Phone: +351 217999411
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blackcurrant supplementation to test bone density changes in postmenopausal women
This study tests whether taking blackcurrant extract can help improve bone density in postmenopausal women by affecting the gut microbiome.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Ashoka Bark and Shatavari for Menopause
This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
Pain and period life: does menstrual cycle or menopause change pain during root canals?
This study will see if pain during a root canal varies with menstrual cycle phase or menopausal status in adult patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.